The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

著者: Mark J. Millan, Alain P. Gobert, F. Lejeune, A Dekeyne, Adrian Newman‐Tancredi, Valérie Pasteau, Jean‐Michel Rivet, Didier Cussac - Journal of Pharmacology and Experimental Therapeutics 2003 被引用: 512